Back
ESC Premium Access

Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab

Session: Immuno-inflammation as therapeutic target in heart failure
Topic: Leukocytes, Inflammation, Immunity
Speaker: Doctor P. Ridker (Boston, US)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
37 presentations
7 followers

4 more presentations in this session

PD1-blocking immune checkpoint inhibitor therapy for malignant melanoma induces left ventricular dysfunction

Speaker: Doctor L. Michel (Essen, DE)

Access
Abstract
Like
Thumbnail

Th17 signature, autoimmunity and differentially expressed genes in cardiomyopathy and heart failure

Speaker: Professor M. Cunningham (Oklahoma City, US)

Access
Abstract
Like
Thumbnail

Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy

Speaker: Mr M. Podaru (London, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Effects of a selective small-molecule formyl peptide receptor 2 agonist on post myocardial inflammation and left ventricular structure-function relationships

Speaker: Doctor R. Garcia (Princeton, US)

Access
Abstract
Like
Thumbnail

Access the full session

Immuno-inflammation as therapeutic target in heart failure

Speakers: Doctor P. Ridker, Doctor L. Michel, Professor M. Cunningham, Mr M. Podaru, Doctor R. Garcia
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources